SHINE Technologies

Janesville,  WI 
United States
https://www.shinefusion.com/
  • Booth: 601

SHINE Technologies is a next-generation fusion technology company headquartered in Janesville, Wisconsin. Their proprietary isotope production processes create n.c.a. lutetium-177 (Lu-177), crucial for therapeutic medical procedures. SHINE is producing and shipping n.c.a. Lu-177, with a Drug Master File established with the U.S. Food and Drug Administration. SHINE is expected to produce up to 200,000 doses per year. Learn more at https://www.shinefusion.com/ and @shinefusion.


 Products

  • Ilumira (n.c.a. lutetium 177)
    Ilumira (n.c.a. lutetium-177; Lu-177) is a powerful radioisotope that is revolutionizing cancer care. When paired with a cancer-seeking molecule, Ilumira precisely targets tumors and metastases, delivering a potent dose of radiation to kill cancer cells while minimizing harm to healthy tissue....